113 related articles for article (PubMed ID: 3531116)
1. Enhancement of radiation-induced cell kill by platinum complexes (carboplatin and iproplatin) in V79 cells.
O'Hara JA; Douple EB; Richmond RC
Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1419-22. PubMed ID: 3531116
[TBL] [Abstract][Full Text] [Related]
2. Interaction of platinum drugs with clinically relevant x-ray doses in mammalian cells: a comparison of cisplatin, carboplatin, iproplatin, and tetraplatin.
Skov K; MacPhail S
Int J Radiat Oncol Biol Phys; 1991 Feb; 20(2):221-5. PubMed ID: 1991682
[TBL] [Abstract][Full Text] [Related]
3. Carboplatin as a potentiator of radiation therapy.
Douple EB; Richmond RC; O'Hara JA; Coughlin CT
Cancer Treat Rev; 1985 Sep; 12 Suppl A():111-24. PubMed ID: 3910216
[TBL] [Abstract][Full Text] [Related]
4. Radiopotentiation by the oral platinum agent, JM216: role of repair inhibition.
Amorino GP; Freeman ML; Carbone DP; Lebwohl DE; Choy H
Int J Radiat Oncol Biol Phys; 1999 May; 44(2):399-405. PubMed ID: 10760436
[TBL] [Abstract][Full Text] [Related]
5. Radiosensitization in vitro by cis-diammine (1,1-cyclobutanedicarboxylato) platinum(II) (carboplatin, JM8) and ethylenediammine-malonatoplatinum(II) (JM40).
Begg AC; van der Kolk PJ; Emondt J; Bartelink H
Radiother Oncol; 1987 Jun; 9(2):157-65. PubMed ID: 3303163
[TBL] [Abstract][Full Text] [Related]
6. The influence of platinum drugs on the radiation response of rat kidneys.
van Rongen E; Kuijpers WC; Baten-Wittwer A
Radiother Oncol; 1994 May; 31(2):138-50. PubMed ID: 8066193
[TBL] [Abstract][Full Text] [Related]
7. The radiomimetic properties of a platinum drug.
Barot HA; Laverick M; Nias AH
Br J Radiol; 1985 Jan; 58(685):51-62. PubMed ID: 3840711
[TBL] [Abstract][Full Text] [Related]
8. Carboplatin enhances the production and persistence of radiation-induced DNA single-strand breaks.
Yang LX; Douple EB; O'Hara JA; Wang HJ
Radiat Res; 1995 Sep; 143(3):302-8. PubMed ID: 7652168
[TBL] [Abstract][Full Text] [Related]
9. Isobologram analysis of the combined effects of anti-tumour platinum complexes and ionizing radiation on mammalian cells.
Szumiel I; Nias AH
Br J Cancer; 1980 Aug; 42(2):292-6. PubMed ID: 7426336
[TBL] [Abstract][Full Text] [Related]
10. Cross resistance studies with L1210 leukemia subline single and double resistant to cisplatin and iproplatin (CHIP).
Hrubisko M; Ujházy V
Neoplasma; 1990; 37(6):631-8. PubMed ID: 2274083
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of side effects of platinum complexes (CDDP, CBDCA, CHIP) on rat bone marrow.
Prajda N; Kralovánszky J; Gal F; Kiss F; Kerpel-Fronius S
In Vivo; 1989; 3(4):267-70. PubMed ID: 2519864
[TBL] [Abstract][Full Text] [Related]
12. Irradiation enhances cellular uptake of carboplatin.
Yang LX; Douple EB; Wang HJ
Int J Radiat Oncol Biol Phys; 1995 Oct; 33(3):641-6. PubMed ID: 7558954
[TBL] [Abstract][Full Text] [Related]
13. An in vitro study comparing the cytotoxicity of three platinum complexes with regard to the effect of thiol depletion.
Smith E; Brock AP
Br J Cancer; 1988 Jun; 57(6):548-52. PubMed ID: 3044430
[TBL] [Abstract][Full Text] [Related]
14. Absolute and relative activities of platinum-complexes on human tumors as evaluated by an antimetabolic in vitro assay.
Daidone MG; Silvestrini R; Zaffaroni N; Grignolio E; Landoni F
Invest New Drugs; 1987; 5(3):245-50. PubMed ID: 3312080
[TBL] [Abstract][Full Text] [Related]
15. Quantitative ultrastructural effects of cisplatin (Platinol), carboplatin (JM8), and iproplatin (JM9) on neurons of freshwater snail Lymnaea stagnalis.
Müller LJ; Moorer-van Delft CM; Roubos EW; Vermorken JB; Boer HH
Cancer Res; 1992 Feb; 52(4):963-73. PubMed ID: 1737358
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness in inhibition of recovery of cell survival by cisplatin and carboplatin: influence of treatment sequence.
Schwachöfer JH; Crooijmans RP; Hoogenhout J; Kal HB; Theeuwes AG
Int J Radiat Oncol Biol Phys; 1991 Jun; 20(6):1235-41. PubMed ID: 2045298
[TBL] [Abstract][Full Text] [Related]
17. Comparison of intestinal toxic effects of platinum complexes: cisplatin (CDDP), carboplatin (CBDCA), and iproplatin (CHIP).
Kralovánszky J; Prajda N; Kerpel-Fronius S; Gál F; Kiss F
Cancer Chemother Pharmacol; 1988; 21(1):40-4. PubMed ID: 3277733
[TBL] [Abstract][Full Text] [Related]
18. The mutagenic and carcinogenic properties of three second generation antitumour platinum compounds: a comparison with cisplatin.
Chibber R; Ord MJ
Eur J Cancer Clin Oncol; 1989 Jan; 25(1):27-33. PubMed ID: 2646132
[TBL] [Abstract][Full Text] [Related]
19. Enhanced radiation-induced cell killing by carboplatin in cells of repair-proficient and repair-deficient cell lines.
Yang L; Douple EB; O'Hara JA; Crabtree RA; Eastman A
Radiat Res; 1995 Nov; 144(2):230-6. PubMed ID: 7480650
[TBL] [Abstract][Full Text] [Related]
20. Radiation reduces carboplatin sensitivity and enhances nedaplatin sensitivity in cervical squamous cell carcinoma in vitro.
Tanaka T; Yukawa K; Umesaki N
Eur J Gynaecol Oncol; 2007; 28(5):352-5. PubMed ID: 17966212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
